DAWN — Day One Biopharmaceuticals, Inc. | XLV Holdings | StockAdder

(DAWN)

Day One Biopharmaceuticals, Inc.

Live chart and latest DAWN stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

DAWN News

Day One Biopharmaceuticals stock reaches 52-week high of $21.48

Apr 13, 2026 Stock Titan

Access Industries group tenders Day One (DAWN) 12.9M-share stake at $21.50

Apr 13, 2026 Yahoo Finance

Day One (DAWN) Soars 100% on $2.5-Billion Merger

Mar 7, 2026 simplywall.st

Optimistic Investors Push Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Up 31% But Growth Is Lacking

Jan 21, 2026 Quiver Quantitative

Day One Biopharmaceuticals Reports 172% Year-over-Year Growth in 2025 Net Product Revenue, Projects 2026 Revenue Between $225 Million and $250 Million | DAWN Stock News

Jan 11, 2026 Stock Titan

[SC TO-T/A] Day One Biopharmaceuticals, Inc. Amended Third-Party Tender Offer | DAWN SEC Filing - Form SC TO-T/A

Apr 14, 2026 Servier

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

Mar 6, 2026 Zacks Investment Research

Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet

Jan 15, 2026 Investor's Business Daily

Why A 'White Knight' Could Still Fight For Day One Bio

Mar 6, 2026 Yahoo Finance

Day One (DAWN) Climbs to 3-Year High on $2.5-Billion Merger

Mar 6, 2026 Stock Titan

[SC 14D9/A] Day One Biopharmaceuticals, Inc. Amended Tender Offer Recommendation

Apr 14, 2026 Investing.com

Day One Biopharmaceuticals stock surges on Servier buyout deal

Mar 6, 2026 Yahoo Finance

Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?

Jan 13, 2026 Yahoo Finance

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates

Feb 24, 2026 Stock Titan

Servier (DAWN) offers $21.50 in cash to buy Day One Biopharma shares